Dr. Antonio Calles 🫁🚭· @Tony_Calles · X·· 1 day agoScore45
Body · original
Dr. Egbert Smit cooling down expectations on ADCs in NSCLC.
☑️ Biomarker driven selection needed.
☑️ Mechanistic explanation on outcomes by different payloads
☑️ SCC histology to be excluded from Trop2 ADCs given the detrimental efficacy
#ESMO26 #LCSM
11 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
2631ROmatched by Rapid oral 1: NSCLC, metastatic
First-line BAT8008 (TROP2-ADC) plus BAT1308 (anti-PD-1) for advanced NSCLC: Results from a multicenter phase 2 study
https://esmocongress.esmo.orgSource: Dr. Antonio Calles 🫁🚭 · x.com